Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3

Jennifer M. Atkinson(University of Pittsburgh), Márcio F. Chedid(Conselho Nacional de Desenvolvimento Científico e Tecnológico)
PLoS ONE
April 27, 2015
Cited by 107


Related Papers

No related papers found

Powered by citation graph analysis